OncoProtoRx Memorial Cancer Institute

Patient Anthropometrics & Live Renal / BSA Engine

Calculated BSA (Mosteller) DuBois: 1.73 m²
1.73 m²
Cockcroft-Gault CrCl Renal Function
84.8 mL/min
Calvert AUC 5 Dose Target AUC × (CrCl + 25)
549 mg
Diagnosis / Stage

Select Institutional Protocol

Consultant Verification Sign-Off

Cytotoxic Dose Calculation & Toxicity Reductions

Adjust individual drug percentages for hematological/hepatic toxicity or apply clinical dose rounding.

Download Official Branded Protocol

Generates a hospital-branded A4 Chemotherapy Order Sheet with your uploaded institution logo and consultant verification footer.

Memorial Regional Cancer Institute

Department of Medical & Radiation Oncology

142 Healthcare Avenue, Sector 5 • Emergency Onco Helpline: +91 98000-00000

NABH Accredited Cancer Center

CHEMOTHERAPY ORDER CHART

DOC-ID: ONCO-RX-2026

Patient Name Rameshwar Prasad
UHID / MRN ONC-2026-8492
Age / Sex 54 Yrs / M
Confirmed Diagnosis & Stage Ca Oropharynx - Stage III (cT3N1M0)
Cycle & Day 1 Date Cycle 1 | 2026-10-29
Allergies No Known Drug Allergy
Height / Weight 168 cm / 64 kg
Calculated BSA 1.73 m²
Sr. Creatinine 0.90 mg/dL
CrCl (Cockcroft-Gault) 84.8 mL/min
HEAD & NECK / CERVIX

Weekly Cisplatin (40 mg/m²) — Concurrent Chemoradiation

Repeat Every 7 Days (Weekly × 6–7 Cycles) Emetogenic Risk: High • Reference: NCCN v2026
Mandatory Pre-Chemo Thresholds: ANC ≥ 1,500/µL | Platelets ≥ 100,000/µL | Sr. Cr < 1.5 mg/dL | Audiometry baseline
[   ] Informed Consent Signed [   ] Patency of IV / Chemo Port Checked

Part A: Pre-Medications & Pre-Chemotherapy Hydration (Chronological Order)

Seq Medication / Hydration Fluid Dose Route Diluent & Infusion Duration Time / Nurse Sign

Part B: Cytotoxic Chemotherapy Agents (Patient-Specific Calculated Doses)

Day Cytotoxic Agent & Safety Alert Protocol Dose % Mod Final Patient Dose Diluent, Route & Duration Start / Stop / 2-RN

Part C: Post-Chemotherapy Hydration, Flush & Supportive Care

Timing Medication / Supportive Instruction Dose & Route Clinical Administration Instructions Nurse Sign
Institutional Clinical & Nursing Precautions:

Prescribing Oncologist / Resident Sign Oncology Pharmacist Verification
Date & Time: ___________________ Dispensed By: _________________